ADVI Expert Discusses Inflation Reduction Act with Pink Sheet
In this Pink Sheet article, ADVI’s Lindsay Bealor Greenleaf, vice president and head of policy and reimbursement, shares her insights on the first ten drugs on the Medicare negotiation list and some of the factors that went into identifying the drugs.
On August 29, 2023, in this Pink Sheet article, ADVI’s Lindsay Bealor Greenleaf, vice president and head of policy and reimbursement, shares her insights on the first ten drugs on the Medicare negotiation list and some of the factors that went into identifying the drugs. Read more about Lindsay’s insights and predictions for future drug lists here.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.